Streetbeat News

Regulatory

ARWR

Arrowhead Pharmaceuticals (ARWR) shares rose by 6% to $27.54 after presenting promising preclinical data on ARO-INHBE at the American Diabetes Association 84th Scientific Sessions. The data showed significant gene silencing and potential benefits in weight and fat mass reduction. Arrowhead plans to seek regulatory clearance for clinical trials in late 2024.

Portfolio Pulse from Henry Khederian

June 24, 2024 | 8:24 pm

RIGL

Rigel Pharmaceuticals has completed the transfer of the New Drug Application for GAVRETO, a treatment for certain types of cancer. GAVRETO will be available in the U.S. starting June 27, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 8:11 pm

VTVT

vTv Therapeutics has screened the first patient in its CATT1 pivotal trial for Cadisegliatin, a potential first-in-class oral liver selective glucokinase activator for Type 1 Diabetes (T1D). The drug has been granted Breakthrough Therapy designation by the FDA and has been dosed in over 500 subjects, including 300 patients with diabetes.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 8:05 pm

POOL

Trading for POOL Corporation (POOL) was halted at 4:00:10 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 8:00 pm

AZN

GEHC

JNJ

PFE

RHHBY

The U.S. Supreme Court has backed 21 pharmaceutical and medical equipment companies, including AstraZeneca, Pfizer, GE Healthcare, Johnson & Johnson, and Roche, in a lawsuit accusing them of funding terrorism in Iraq. The case has been sent back to a lower court for reconsideration.

Portfolio Pulse from Vandana Singh

June 24, 2024 | 7:47 pm

BMWYY

DRPRY

F

GM

MBGYY

RIVN

TSLA

Germany and China are negotiating to prevent a tariff war on electric vehicles (EVs) that could impact carmakers in both regions. The EU's proposed tariffs on Chinese EVs could lead to retaliatory tariffs from China on EU-made cars, affecting luxury German brands. The U.S. has also increased tariffs on Chinese EVs, benefiting domestic carmakers.

Portfolio Pulse from Natan Ponieman

June 24, 2024 | 7:46 pm

DDC

DDC Enterprise announced it is offering Class A Ordinary Shares in a high-risk investment opportunity exempt from U.S. Securities Law registration. The shares come with transfer restrictions and will be issued once NYSE American compliance is fulfilled. No size or price per share was disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:43 pm

NVO

U.S. Senate Health Committee Chairman Sanders has announced that the CEO of Novo Nordisk will testify before the committee on September 24.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:15 pm

SPY

Federal Reserve's Daly mentioned that contacts have indicated AI is reducing costs and could act as a deflationary force.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:02 pm

KBE

KRE

SPY

XLF

The Federal Reserve has proposed a weaker version of the bank capital overhaul, which could impact the financial sector. This proposal may affect various financial ETFs and stocks, including KBE, KRE, SPY, and XLF.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 7:01 pm